| Abstract | Epoetin alfa therapy has been proven effective in treating anemia in dialysis patients; it increases the hematocrit (HCT) and improves the quality of life. The reimbursement policy for Epoetin alfa therapy is very important to dialysis patients; nurses need to understand the policy to help patients with reimbursement and to comply with the provisions for patient monitoring and education. |
| Authors | W I Roe |
| Journal | ANNA journal / American Nephrology Nurses' Association
(ANNA J)
Vol. 19
Issue 2
Pg. 198-9
(Apr 1992)
ISSN: 8750-0779 UNITED STATES |
| PMID | 1586234
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
| Chemical References |
|
| Topics |
- Anemia
(drug therapy, etiology, nursing)
- Erythropoietin
(administration & dosage, therapeutic use)
- Humans
- Kidney Failure, Chronic
(complications, economics)
- Male
- Middle Aged
- Reimbursement Mechanisms
- Self Administration
|
